118 related articles for article (PubMed ID: 27018418)
21. High-grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study.
Thamsborg LH; Napolitano G; Larsen LG; Lynge E
Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1290-1296. PubMed ID: 32754966
[TBL] [Abstract][Full Text] [Related]
22. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study.
Loopik DL; IntHout J; Melchers WJG; Massuger LFAG; Bekkers RLM; Siebers AG
Eur J Cancer; 2020 Jan; 124():102-109. PubMed ID: 31760309
[TBL] [Abstract][Full Text] [Related]
23. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
[TBL] [Abstract][Full Text] [Related]
24. Incidence and costs of cervical intraepithelial neoplasia in the Korean population.
Chang HK; Seo SS; Myong JP; Yu YL; Byun SW
J Gynecol Oncol; 2019 May; 30(3):e37. PubMed ID: 30887758
[TBL] [Abstract][Full Text] [Related]
25. A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland.
Hinkula M; Pukkala E; Kyyrönen P; Laukkanen P; Koskela P; Paavonen J; Lehtinen M; Kauppila A
Br J Cancer; 2004 Mar; 90(5):1025-9. PubMed ID: 14997202
[TBL] [Abstract][Full Text] [Related]
26. Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24.
Sasieni P; Castanon A
J Med Screen; 2012 Sep; 19(3):127-32. PubMed ID: 23093730
[TBL] [Abstract][Full Text] [Related]
27. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
[TBL] [Abstract][Full Text] [Related]
28. Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types.
Sand FL; Munk C; Frederiksen K; Junge J; Iftner T; Dehlendorff C; Kjaer SK
Int J Cancer; 2019 Apr; 144(8):1975-1982. PubMed ID: 30246864
[TBL] [Abstract][Full Text] [Related]
29. Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
Orumaa M; Leinonen MK; Campbell S; Møller B; Myklebust TÅ; Nygård M
Int J Cancer; 2019 Nov; 145(10):2629-2638. PubMed ID: 30734284
[TBL] [Abstract][Full Text] [Related]
30. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.
Strander B; Hällgren J; Sparén P
BMJ; 2014 Jan; 348():f7361. PubMed ID: 24423603
[TBL] [Abstract][Full Text] [Related]
31. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
32. HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3.
Baandrup L; Munk C; Andersen KK; Junge J; Iftner T; Kjær SK
Gynecol Oncol; 2012 Feb; 124(2):281-5. PubMed ID: 22036987
[TBL] [Abstract][Full Text] [Related]
33. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Obel N; Lebech AM
HIV Med; 2016 Jan; 17(1):7-17. PubMed ID: 26058995
[TBL] [Abstract][Full Text] [Related]
34. Carcinoma of the uterine cervix and dysplasia in Greenland.
Nielsen NH; Mikkelsen F; Hansen JP
Acta Pathol Microbiol Scand A; 1978 Jan; 86(1):36-44. PubMed ID: 636887
[TBL] [Abstract][Full Text] [Related]
35. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
[TBL] [Abstract][Full Text] [Related]
36. Declines in Human Papillomavirus (HPV)-Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008-2015.
Niccolai LM; Meek JI; Brackney M; Hadler JL; Sosa LE; Weinberger DM
Clin Infect Dis; 2017 Sep; 65(6):884-889. PubMed ID: 28520854
[TBL] [Abstract][Full Text] [Related]
37. Histological outcomes in HPV-screened elderly women in Denmark.
St-Martin G; Viborg PH; Andersen ABT; Andersen B; Christensen J; Ejersbo D; Heje HN; Jochumsen KM; Johansen T; Larsen LG; Lynge E; Serizawa RR; Waldstrøm M
PLoS One; 2021; 16(2):e0246902. PubMed ID: 33571319
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
39. Selected demographic characteristics of Israeli Jewish women with high-grade cervical intraepithelial neoplasia (CIN3): a population-based study.
Kogan L; Menczer J; Shejter E; Liphshitz I; Barchana M
Arch Gynecol Obstet; 2011 Feb; 283(2):329-33. PubMed ID: 20191281
[TBL] [Abstract][Full Text] [Related]
40. Risk of cervical precancer among HPV-negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study.
Inturrisi F; Rozendaal L; Veldhuijzen NJ; Heideman DAM; Meijer CJLM; Berkhof J
PLoS Med; 2022 Oct; 19(10):e1004115. PubMed ID: 36306283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
